Acute Portal Vein Thrombosis Secondary to COVID-19 Vaccination.
| Autor: | Repp ML; Emergency Medicine, University of Arizona, Tucson, USA., Cohen S; Emergency Medicine, University of Texas-Southwestern, Dallas, USA., Kibbey C; Emergency Medicine, University of Texas-Southwestern, Dallas, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2022 Jul 13; Vol. 14 (7), pp. e26825. Date of Electronic Publication: 2022 Jul 13 (Print Publication: 2022). |
| DOI: | 10.7759/cureus.26825 |
| Abstrakt: | Portal vein thrombosis (PVT) is a partial or complete occlusion of the hepatic portal vein most frequently seen in patients with cirrhotic liver disease. Various non-cirrhotic conditions including inherited prothrombic blood disorders, neoplasms, and inflammatory diseases create hypercoagulable states that predispose individuals to blood clotting. Rarely does an exhaustive workup leave the etiology of a PVT unknown or unclear, and even more uncommon is a potential new etiology suspected. Our patient is a 34-year-old female, with no significant risk factors for pathologic clotting, who was diagnosed with an acute PVT several days after receiving the Moderna coronavirus disease 2019 (COVID-19) vaccine. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2022, Repp et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|